Research Article
Adenocarcinoma with BAC Features Presented as the Nonsolid Nodule Is Prone to Be False-Negative on 18F-FDG PET/CT
Table 1
GGO component, lesion size, SUVmax, and PET/CT positivity in adenocarcinoma lesions with BAC features.
| | Tumor | Number | PET/CT positivity, no. (%) of nodules | SUVmax |
| | GGO component | | = 31.55, = 0.000 | = 20.827, = 0.000 | | GGO nodule | 10 | 0 (0.0) | 1.04 ± 0.43 | | Mixed nodule | 16 | 6 (37.5) | 2.93 ± 2.99 | | Solid nodule | 25 | 24 (96.0) | 8.14 ± 4.11 | | Lesion size (cm) | | = 5.815, = 0.055 | = 21.463, = 0.000 | | 1.1–2.0 | 26 | 13 (50.0) | 2.20 ± 2.51 | | 2.1–3.0 | 18 | 10 (55.6) | 7.46 ± 3.59 | | >3.0 | 7 | 7 (100) | 9.88 ± 5.10 |
|
|
BAC, bronchoalveolar cell carcinoma; GGO, ground-glass opacity; SUVmax, maximum standardized uptake value.
|
